FDA Adverse Event Other Summary report: N

BODY FLUID COLLECTION PAPER '903'

MDR report key: 1880530 · Received October 19, 2010

Report

Report Number
1281317-2010-00004
Event Type
Other
Date Received
October 19, 2010
Date of Event
September 1, 2010
Report Date
September 22, 2010
Manufacturer
GE HEALTHCARE BI-SCIENCES CORP
Product Code
JKA
PMA / PMN Number
K932661
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MD, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE IS INDICATED AS A BLOOD SPECIMEN RECEPTACLE. THE BLOOD IS TRANSPORTED TO A LABORATORY AS DRIED BLOOD SPOTS. NO OTHER INDICATIONS OR CLAIMS ARE SUPPORTED. THE COMPLAINT DESCRIBED BY THE CUSTOMER IS OF LOW ASSAYS OF BIOTINIDASE FROM BLOOD SAMPLES APPLIED TO (B)(4). THE CUSTOMER ALLEGES THAT THE LOW ASSAY IS CAUSED BY THE (B)(4) LOT W092. INVESTIGATION IN PROCESS. A FOLLOW UP REPORT WILL BE SUPPLIED IN 30 DAYS, ON OR BEFORE (B)(6) 2010.

Description of Event or Problem · 1

THE DEVICE IS INDICATED FOR USE BY HEALTH CARE PROFESSIONALS IN THE COLLECTION AND TRANSPORT TO A CLINICAL LABORATORY OF NEONATE BLOOD AS DRIED BLOOD SPOTS. THE NEONATE BLOOD IS TESTED TO SCREEN THE INFANT FOR CONGENITAL ABNORMALITIES OF METABOLISM AND OTHER CONDITIONS. THE DEVICE IS PRESENTED AS JOINED PARTS WHICH CONSTITUTE THE TOTAL DEVICE PRESENTATION; FORMS PROVIDING THE INFANTS DEMOGRAPHIC DETAILS, AND THE (B)(4) TO WHICH CAPILLARY BLOOD SPOTS ARE APPLIED. THE DEVICE IS INDICATED AS A BLOOD SPECIMEN RECEPTACLE. THE BLOOD IS TRANSPORTED TO A LABORATORY AS DRIED BLOOD SPOTS. NO OTHER INDICATIONS OR CLAIMS ARE SUPPORTED. THE COMPLAINT DESCRIBED BY THE CUSTOMER IS OF LOW ASSAYS OF BIOTINIDASE FROM BLOOD SAMPLES APPLIED TO (B)(4). THE CUSTOMER ALLEGES THAT THE LOW ASSAY IS CAUSED BY THE (B)(4) LOT W092.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 BODY FLUID COLLECTION PAPER '903' JKA GE HEALTHCARE BI-SCIENCES CORP 10534536 W092/6871110

Patients

Seq Age Sex Outcome Treatment
1